U.S. markets open in 7 hours 2 minutes
  • S&P Futures

    4,468.50
    +22.75 (+0.51%)
     
  • Dow Futures

    34,883.00
    +209.00 (+0.60%)
     
  • Nasdaq Futures

    15,383.75
    +65.00 (+0.42%)
     
  • Russell 2000 Futures

    2,260.40
    +16.40 (+0.73%)
     
  • Crude Oil

    75.06
    +1.08 (+1.46%)
     
  • Gold

    1,756.60
    +4.90 (+0.28%)
     
  • Silver

    22.60
    +0.18 (+0.78%)
     
  • EUR/USD

    1.1721
    +0.0003 (+0.02%)
     
  • 10-Yr Bond

    1.4600
    0.0000 (0.00%)
     
  • Vix

    17.75
    -0.88 (-4.72%)
     
  • GBP/USD

    1.3667
    -0.0013 (-0.10%)
     
  • USD/JPY

    110.6970
    +0.0120 (+0.01%)
     
  • BTC-USD

    44,138.68
    +1,976.09 (+4.69%)
     
  • CMC Crypto 200

    1,100.87
    -2.19 (-0.20%)
     
  • FTSE 100

    7,051.48
    -26.87 (-0.38%)
     
  • Nikkei 225

    30,240.06
    -8.75 (-0.03%)
     

Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000

·1 min read

Northampton, MA --News Direct-- Illumina

Illumina's NextSeq 1000/2000 sequencing systems are based on a technology that leverages light to decipher the genome. The instruments are used, among other things, to determine the genetic profile of the SARS-CoV-2 virus and its variants. The housing is made of high-grade aluminium and reflects the technological quality and precision of the instruments. The most striking design feature is the circumferential light bar that uses colour changes to make the working status clearly visible from all directions. The digital interface takes up the product aesthetics and creates a seamless user experience.

Statement by the Jury

The high design quality of the NextSeq 1000/2000 sequencing system manifests in elegant contours and the exciting use of light.

View additional multimedia and more ESG storytelling from Illumina on 3blmedia.com

View source version on newsdirect.com: https://newsdirect.com/news/illumina-wins-reddot-2021-award-genomic-sequencing-system-nextseq-1000-2000-155872204